A bipartisan Senate duo is introducing legislation to make pharmacy-benefit managers, the middlemen of drug pricing, divest their pharmacy businesses within three years.

Sens. Elizabeth Warren (D-MA) and Josh Hawley (R-MO) are co-sponsoring the bill, acting on years of scrutiny from the Federal Trade Commission and Congress toward companies who own health insurers, or pharmacy-benefit managers, known as PBMs.

Recommended Stories

HHS and FTC team up to target pharmaceutical middlemen for drug shortages

Republicans and Democrats eye drug pricing reform in new Congress

FTC sues top three pharmacy middlemen over insulin prices